NHS patients missing out on new medicines that could extend lives

Pharma Times

13 May 2022 - Data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out

New data by PwC for the Association of the British Pharmaceutical Industry highlights the potential benefits of increased investment in clinically and cost-effective new medicines to patients, society and the economy.

Read Pharma Times article

Read ABPI press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Medicine , Market access